Nathan Kline Institute for Psychiatric Research
nki.rfmh.orgTotal trials
23
Active
1
Phase 3
1
Total enrollment
1,681
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Schizophrenia17
- Schizoaffective Disorder6
- Cigarette Smoking2
- Diabetes2
- Cognition1
- Mental Health1
- Insulin Resistance1
- Cognitive Impairment1
Frequently asked questions about Nathan Kline Institute for Psychiatric Research
- How many clinical trials does Nathan Kline Institute for Psychiatric Research have on ClinicalTrials.gov?
- Nathan Kline Institute for Psychiatric Research is listed as the lead sponsor on 23 clinical trials in ClinicalTrials.gov, 1 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Nathan Kline Institute for Psychiatric Research's trials are in Phase 3?
- 1 of Nathan Kline Institute for Psychiatric Research's trials are in Phase 3.
- What therapeutic areas does Nathan Kline Institute for Psychiatric Research focus on?
- Nathan Kline Institute for Psychiatric Research's most-studied conditions on ClinicalTrials.gov are Schizophrenia, Schizoaffective Disorder, Cigarette Smoking, Diabetes, Cognition.